Vagal afferents sense meal-associated gastrointestinal and pancreatic hormones: Mechanism and physiological role

Neuropeptides

Volumn 46, Issue 6, 2012, Pages 291-297

  Iwasaki, Yusaku ^a   Yada, Toshihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cholecystokinin; Food intake; Glucagon like peptide 1; Nesfatin 1; Nodose ganglion; Pancreatic polypeptide; Peptide YY; Vagal afferent nerves

Indexed keywords

CALCIUM ION; CHOLECYSTOKININ; GASTROINTESTINAL HORMONE; NESFATIN 1; PANCREAS HORMONE; PANCREAS POLYPEPTIDE; PEPTIDE YY [3-36]; UNCLASSIFIED DRUG;

FEEDING BEHAVIOR; FOOD INTAKE; HORMONE ACTION; HORMONE RELEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SATIETY; VAGUS NERVE;

ANIMALS; CALCIUM-BINDING PROTEINS; CHOLECYSTOKININ; DNA-BINDING PROTEINS; EATING; GASTROINTESTINAL HORMONES; HUMANS; NERVE TISSUE PROTEINS; NEURONS, AFFERENT; NEUROPEPTIDE Y; PANCREATIC HORMONES; VAGUS NERVE;

EID: 84869864290     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.08.009     Document Type: Review

References (69)

1. 3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005, 1044:127-131.
2. Adrian T.E., Bloom S.R., Bryant M.G., Polak J.M., Heitz P.H., Barnes A.J. Distribution and release of human pancreatic polypeptide. Gut 1976, 17:940-944.
3. Asakawa A., Inui A., Yuzuriha H., Ueno N., Katsuura G., Fujimiya M., Fujino M.A., Niijima A., Meguid M.M., Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003, 124:1325-1336.
4. Asin K.E., Gore P.A., Bednarz L., Holladay M., Nadzan A.M. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats. Brain Res. 1992, 571:169-174.
5. Banks W.A., Kastin A.J., Jaspan J.B. Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice. Pharmacol. Biochem. Behav. 1995, 51:139-147.
6. 3-36 physiologically inhibits food intake. Nature 2002, 418:650-654.
7. Batterham R.L., Heffron H., Kapoor S., Chivers J.E., Chandarana K., Herzog H., Le Roux C.W., Thomas E.L., Bell J.D., Withers D.J. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006, 4:223-233.
8. Batterham R.L., Le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., Frost G.S., Ghatei M.A., Bloom S.R. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 2003, 88:3989-3992.
9. Broberger C., Holmberg K., Kuhar M.J., Hokfelt T. Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety. Proc. Natl. Acad. Sci. USA 1999, 96:13506-13511.
10. Broberger C., Holmberg K., Shi T.J., Dockray G., Hokfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res. 2001, 903:128-140.
11. Burdyga G., Lal S., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci. 2004, 24:2708-2715.
12. 3-36 potently inhibits food intake in rats. Endocrinology 2005, 146:879-888.
13. Corp E.S., Curcio M., Gibbs J., Smith G.P. The effect of centrally administered CCK-receptor antagonists on food intake in rats. Physiol. Behav. 1997, 61:823-827.
14. Cummings D.E., Overduin J. Gastrointestinal regulation of food intake. J. Clin. Invest. 2007, 117:13-23.
15. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
16. De Lartigue G., Dimaline R., Varro A., Dockray G.J. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J. Neurosci. 2007, 27:2876-2882.
17. De Lartigue G., Dimaline R., Varro A., Raybould H., De la Serre C.B., Dockray G.J. Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons. Gastroenterology 2010, 138:1479-1490.
18. 1-36. Peptides 1989, 10:797-803.
19. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002, 23:251-261.
20. Fan W., Ellacott K.L., Halatchev I.G., Takahashi K., Yu P., Cone R.D. Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat. Neurosci. 2004, 7:335-336.
21. Foo K.S., Brauner H., Ostenson C.G., Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J. Endocrinol. 2010, 204:255-263.
22. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 1973, 84:488-495.
23. Gonzalez R., Perry R.L., Gao X., Gaidhu M.P., Tsushima R.G., Ceddia R.B., Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011, 152:3628-3637.
24. Gonzalez R., Tiwari A., Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem. Biophys. Res. Commun. 2009, 381:643-648.
25. 3-36. Regul. Pept. 1994, 51:151-159.
26. Hamilton R.B., Norgren R. Central projections of gustatory nerves in the rat. J. Comp. Neurol. 1984, 222:560-577.
27. Iwasaki, Y., Kakei, M., Nakabayasi, H., Ayush, E.A., Hirano-Kodaira, M., Maejima, Y., Yada, T., Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons Neuropeptides (in press).
28. 2+ influx through N-type channels. Biochem. Biophys. Res. Commun. 2009, 390:958-962.
29. Iwasaki Y., Tanabe M., Kayama Y., Abe M., Kashio M., Koizumi K., Okumura Y., Morimitsu Y., Tominaga M., Ozawa Y., Watanabe T. Miogadial and miogatrial with alpha, beta-unsaturated 1,4-dialdehyde moieties: novel and potent TRPA1 agonists. Life Sci. 2009, 85:60-69.
30. 2+ in rat nodose ganglion neurons. Auton. Neurosci. 2002, 102:39-44.
31. Kissileff H.R., Pi-Sunyer F.X., Thornton J., Smith G.P. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 1981, 34:154-160.
32. 3-36-induced feeding reduction in rats. Endocrinology 2005, 146:2369-2375.
33. Kopin A.S., Mathes W.F., McBride E.W., Nguyen M., Al-Haider W., Schmitz F., Bonner-Weir S., Kanarek R., Beinborn M. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J. Clin. Invest. 1999, 103:383-391.
34. 2+ signal transduction in vagal nodose ganglia. Am. J. Physiol. Gastrointest. Liver. Physiol. 2002, 282:G1002-G1008.
35. Liddle R.A., Goldfine I.D., Williams J.A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984, 87:542-549.
36. Linnestad P., Schrumpf E. Pancreatic polypeptide release stimulated by food, secretin and cholecystokinin in chronic pancreatitis. Scand. J. Gastroenterol. 1983, 18:385-389.
37. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh-I S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009, 10:355-365.
38. Malaisse-Lagae F., Carpentier J.L., Patel Y.C., Malaisse W.J., Orci L. Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia 1977, 33:915-917.
39. Martins C., Morgan L.M., Bloom S.R., Robertson M.D. Effects of exercise on gut peptides, energy intake and appetite. J. Endocrinol. 2007, 193:251-258.
40. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50:143-150.
41. Moran T.H., Ameglio P.J., Schwartz G.J., McHugh P.R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 1992, 262:R46-R50.
42. Morton G.J., Schwartz M.W. The NPY/AgRP neuron and energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 2001, 25(Suppl 5):S56-S62.
43. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., Kigoshi T., Nakayama K., Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton. Neurosci. 2004, 110:36-43.
44. Nonaka N., Shioda S., Niehoff M.L., Banks W.A. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J. Pharmacol. Exp. Ther. 2003, 306:948-953.
45. Oh-I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
46. Osaki A., Shimizu H., Ishizuka N., Suzuki Y., Mori M., Inoue S. Enhanced expression of nesfatin/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats. Neurosci. Lett. 2012, 521:46-51.
47. Palasz A., Krzystanek M., Worthington J., Czajkowska B., Kostro K., Wiaderkiewicz R., Bajor G. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 2012, 46:105-112.
48. Pan W., Hsuchou H., Kastin A.J. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007, 28:2223-2228.
49. Passaro E., Debas H., Oldendorf W., Yamada T. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation. Brain Res. 1982, 241:335-340.
50. Peters J.H., Ritter R.C., Simasko S.M. Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1544-R1549.
51. Price T.O., Samson W.K., Niehoff M.L., Banks W.A. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007, 28:2372-2381.
52. Reidelberger R.D., Varga G., Solomon T.E. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats. Peptides 1991, 12:1215-1221.
53. Ritter R.C., Ladenheim E.E. Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am. J. Physiol. 1985, 248:R501-R504.
54. Shimizu H., Ohsaki A., Oh-I S., Okada S., Mori M. A new anorexigenic protein, nesfatin-1. Peptides 2009, 30:995-998.
55. Shimizu H., Oh-I S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Eguchi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice. the leptin-independent mechanism. Endocrinology 2009, 150:662-671.
56. Simasko S.M., Wiens J., Karpiel A., Covasa M., Ritter R.C. Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R1303-R1313.
57. Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981, 213:1036-1037.
58. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Monnikes H., Lambrecht N.W., Tache Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor 2 receptor. Endocrinology 2009, 150:4911-4919.
59. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Tache Y., Sachs G., Lambrecht N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009, 150:232-238.
60. Takayanagi Y., Matsumoto H., Nakata M., Mera T., Fukusumi S., Hinuma S., Ueta Y., Yada T., Leng G., Onaka T. Endogenous prolactin-releasing peptide regulates food intake in rodents. J. Clin. Invest. 2008, 118:4014-4024.
61. 3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146:3748-3756.
62. Ueno N., Inui A., Iwamoto M., Kaga T., Asakawa A., Okita M., Fujimiya M., Nakajima Y., Ohmoto Y., Ohnaka M., Nakaya Y., Miyazaki J.I., Kasuga M. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999, 117:1427-1432.
63. Walther C., Morl K., Beck-Sickinger A.G. Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. J. Pept. Sci. 2011, 17:233-246.
64. Woods S.C., Lutz T.A., Geary N., Langhans W. Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2006, 361:1219-1235.
65. Wright J., Campos C., Herzog T., Covasa M., Czaja K., Ritter R.C. Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R448-R455.
66. Zhang A.Q., Li X.L., Jiang C.Y., Lin L., Shi R.H., Chen J.D., Oomura Y. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J. Gastroenterol. 2010, 16:1735-1741.
67. Zheng H., Patterson C., Berthoud H.R. Fourth ventricular injection of CART peptide inhibits short-term sucrose intake in rats. Brain Res. 2001, 896:153-156.
68. Zhu X.G., Greeley G.H., Lewis B.G., Lilja P., Thompson J.C. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. J. Neurosci. Res. 1986, 15:393-403.
69. Zhuo H., Ichikawa H., Helke C.J. Neurochemistry of the nodose ganglion. Prog. Neurobiol. 1997, 52:79-107.